Cancer immunotherapy by dendritic cells
- PMID: 18799145
- DOI: 10.1016/j.immuni.2008.08.004
Cancer immunotherapy by dendritic cells (VSports在线直播)
Abstract
Cancerous lesions promote tumor growth, motility, invasion, and angiogenesis via oncogene-driven immunosuppressive leukocyte infiltrates, mainly myeloid-derived suppressor cells, tumor-associated macrophages, and immature dendritic cells (DCs). In addition, many tumors express or induce immunosuppressive cytokines such as TGF-beta and IL-10. As a result, tumor-antigen crosspresentation by DCs induces T cell anergy or deletion and regulatory T cells instead of antitumor immunity VSports手机版. Tumoricidal effector cells can be generated after vigorous DC activation by Toll-like receptor ligands or CD40 agonists. However, no single immunotherapeutic modality is effective in established cancer. Rather, chemotherapies, causing DC activation, enhanced crosspresentation, lymphodepletion, and reduction of immunosuppressive leukocytes, act synergistically with vaccines or adoptive T cell transfer. Here, I discuss the considerations for generating promising therapeutic antitumor vaccines that use DCs. .
Publication types
- "VSports手机版" Actions
VSports手机版 - MeSH terms
- "VSports注册入口" Actions
- "VSports在线直播" Actions
- V体育2025版 - Actions
- Actions (V体育官网)
- "VSports app下载" Actions
- "VSports最新版本" Actions
- V体育2025版 - Actions
- Actions (V体育ios版)
Substances
- "VSports在线直播" Actions
- VSports注册入口 - Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
